Screener
Emergent Biosolutions EBS Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $234.3M+66.3% | $156.1M-29.7% | $148.7M-23.6% | $231.1M-21.3% | $140.9M-44.7% | ||
| $97.1M+45.1% | $72M-18.6% | $84.9M-28.1% | $85.9M-29.9% | $66.9M-77.4% | ||
| $137.2M+85.4% | $84.1M-37.1% | $63.8M-16.8% | $145.2M-15.2% | $74M+279% | ||
| 58.6%+6.0pp | 53.9%-6.3pp | 42.9%+3.5pp | 62.8%+4.6pp | 52.5%+68.8pp | ||
| $9.2M-26.4% | $10.5M-30.5% | $12.1M+33.0% | $13.5M-2.2% | $12.5M-61.8% | ||
| $44.6M+2.1% | $46.6M-11.1% | $51.1M-16.0% | $38.9M-49.2% | $43.7M-49.1% | ||
| $359.4M+158% | $145.6M-15.5% | $176.6M-13.5% | $154.6M-32.6% | $139.3M-69.6% | ||
| -$125.1M-7,919% | $10.5M-79.0% | —— | $76.5M+18.6% | $1.6M+101% | ||
| -53.4%-54.5pp | 6.7%-15.7pp | —— | 33.1%+11.1pp | 1.1%+81.0pp | ||
| $10M-32.0% | $11M-25.2% | $14.7M-0.7% | $15.2M+83.1% | $14.7M-37.7% | ||
| -$41.2M-124% | $2.9M-93.2% | -$22.8M-26.0% | -$18.9M-124% | -$18.4M+72.2% | ||
| -$166.3M-890% | $13.4M-85.5% | —— | $57.6M-59.6% | -$16.8M+93.8% | ||
| $13.9M+390% | $6.6M-73.3% | $3.9M+5.4% | $6.4M-76.8% | -$4.8M-136% | ||
| -$180.2M-1,402% | $6.8M-90.0% | —— | $51.2M-55.4% | -$12M+95.8% | ||
| -76.9%-68.4pp | 4.4%-26.2pp | —— | 22.2%-16.9pp | -8.5%+103pp | ||
| -$3.49-1,486% | $0.07-94.1% | —— | $0.91-55.8% | -$0.22+95.9% | ||
| -$101.1M-503% | $34M-54.8% | —— | $99.9M+9.9% | $25.1M+114% | ||
| -43.1%-61.0pp | 21.8%-12.1pp | —— | 43.2%+12.3pp | 17.8%+86.5pp | ||
| -$125.1M-7,919% | $10.5M-79.0% | —— | $76.5M+18.6% | $1.6M+101% |
FAQ
- What is Emergent Biosolutions's revenue?
- Emergent Biosolutions (EBS) generated $770.2M in revenue over the trailing twelve months, down 9.6% year over year.
- Is Emergent Biosolutions profitable?
- Emergent Biosolutions is not currently profitable: it reported a net loss of $134.2M over the trailing twelve months, a 9.6% net margin.
- What are Emergent Biosolutions's profit margins?
- Gross margin is 55.9% and operating margin is 15.0%, with a 9.6% net margin.
- What is Emergent Biosolutions's earnings per share?
- Emergent Biosolutions's diluted EPS over the trailing twelve months is $-2.73.
- Where does Emergent Biosolutions's income statement data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
